Niosomes: A review on niosomal research in the last decade

Abstract In the last one-decade numbers of review and research, articles have been published on niosomes. This shows the interest of researchers in niosomes because of the advantages offered by them over other vesicular carrier systems. Niosomes formation occurs when non-ionic surfactant vesicles assemble themselves. There are several factors like the type of non-ionic surfactant used, method of preparation, the temperature of hydration, etc. which affect the niosome formation. In this review article, we have made an attempt to incorporate all the basic details of niosomes like various methods of preparation, different types of niosomes, factors affecting their formation, characterization of niosome, their applications, routes of administration as well as the advancements taken place in the field of niosomal research with a literature review of research done in the last decade.

[1]  S. Sahoo,et al.  Coformulation of doxorubicin and curcumin in poly(D,L-lactide-co-glycolide) nanoparticles suppresses the development of multidrug resistance in K562 cells. , 2011, Molecular pharmaceutics.

[2]  F. Rinaldi,et al.  Niosomes from 80s to present: the state of the art. , 2014, Advances in colloid and interface science.

[3]  N. Chauhan,et al.  Curcumin Nanoformulation for Cervical Cancer Treatment , 2016, Scientific Reports.

[4]  S. Khoee,et al.  Polymer Systems for Ophthalmic Drug Delivery , 2015 .

[5]  D. Craig,et al.  The effect of processing variables on the physical characteristics of non-ionic surfactant vesicles (niosomes) formed from a hexadecyl diglycerol ether. , 2000, International journal of pharmaceutics.

[6]  Sanyog Jain,et al.  Non-invasive vaccine delivery in transfersomes, niosomes and liposomes: a comparative study. , 2005, International journal of pharmaceutics.

[7]  Y. Byun,et al.  PEG-transferrin conjugated TRAIL (TNF-related apoptosis-inducing ligand) for therapeutic tumor targeting. , 2012, Journal of controlled release : official journal of the Controlled Release Society.

[8]  N. Yuksel,et al.  Characterization of niosomes prepared with various nonionic surfactants for paclitaxel oral delivery. , 2010, Journal of pharmaceutical sciences.

[9]  G. Gutiérrez,et al.  Preparation of water-in-oil-in-water (W1/O/W2) double emulsions containing trans-resveratrol , 2014 .

[10]  J. Natarajan,et al.  A review on novel vesicular drug delivery: proniosomes , 2014, Drug delivery.

[11]  G. Buckton Interfacial Phenomena in Drug Delivery and Targeting , 2000 .

[12]  M. Carafa,et al.  Non-ionic surfactant vesicles in pulmonary glucocorticoid delivery: characterization and interaction with human lung fibroblasts. , 2010, Journal of controlled release : official journal of the Controlled Release Society.

[13]  Raida Al-Kassas,et al.  Niosomes and discomes for ocular delivery of naltrexone hydrochloride: morphological, rheological, spreading properties and photo-protective effects. , 2012, International journal of pharmaceutics.

[14]  A. Florence,et al.  The preparation and properties of niosomes—non‐ionic surfactant vesicles , 1985, The Journal of pharmacy and pharmacology.

[15]  J. Manosroi,et al.  Novel Elastic Nanovesicles for Cosmeceutical and Pharmaceutical Applications , 2009 .

[16]  C. Moonen,et al.  Gene expression and gene therapy imaging , 2007, European Radiology.

[17]  Sanyog Jain,et al.  Non-ionic surfactant based vesicles (niosomes) for non-invasive topical genetic immunization against hepatitis B. , 2005, International journal of pharmaceutics.

[18]  V. Sankar,et al.  Formulation and Optimization of Zidovudine Niosomes , 2010, AAPS PharmSciTech.

[19]  S. Bhaskaran,et al.  Niosomal methotrexate gel in the treatment of localized psoriasis: phase I and phase II studies. , 2007, Indian journal of dermatology, venereology and leprology.

[20]  G. P. Kumar,et al.  Nonionic surfactant vesicular systems for effective drug delivery—an overview , 2011 .

[21]  A. Masotti,et al.  Polyethylenimine bioconjugates for imaging and DNA delivery in vivo. , 2011, Methods in molecular biology.

[22]  Leaf Huang,et al.  Large scale production of DC-Chol cationic liposomes by microfluidization , 1996 .

[23]  M. Saraiva,et al.  Curcumin: A multi-target disease-modifying agent for late-stage transthyretin amyloidosis , 2016, Scientific Reports.

[24]  A. Shnyra,et al.  Autoimmune Mechanisms of Psoriasis: Pathogenic Role of the IL-23/IL-17 Axis , 2018 .

[25]  A. Häkkinen,et al.  The effect of cosolvents on the formulation of nanoparticles from low-molecular-weight poly(I)lactide , 2002, AAPS PharmSciTech.

[26]  G. Fabbrocini,et al.  Nanocarriers for topical administration of resveratrol: a comparative study. , 2013, International journal of pharmaceutics.

[27]  D. Greenblatt,et al.  Ritonavir induces P-glycoprotein expression, multidrug resistance-associated protein (MRP1) expression, and drug transporter-mediated activity in a human intestinal cell line. , 2001, Journal of pharmaceutical sciences.

[28]  Shivani Verma,et al.  Vesicular nanocarrier based treatment of skin fungal infections: Potential and emerging trends in nanoscale pharmacotherapy , 2018, Asian journal of pharmaceutical sciences.

[29]  Masuda,et al.  In vitro and in vivo evaluation of ellagic acid on melanogenesis inhibition , 2000, International journal of cosmetic science.

[30]  Ling Li,et al.  Curcumin-Encapsulated Polymeric Micelles Suppress the Development of Colon Cancer In Vitro and In Vivo , 2015, Scientific Reports.

[31]  H. Junginger,et al.  Preparation and Characterization of Nonionic Surfactant Vesicles , 1996 .

[32]  L. Illum Is nose‐to‐brain transport of drugs in man a reality? , 2004, The Journal of pharmacy and pharmacology.

[33]  F. Iemma,et al.  A new crown ether as vesicular carrier for 5-fluoruracil: synthesis, characterization and drug delivery evaluation. , 2007, Colloids and surfaces. B, Biointerfaces.

[34]  B. P. Srinivasan,et al.  Niosomes as vesicular carriers for delivery of proteins and biologicals , 2011 .

[35]  J. Sullivan,et al.  Treatments for severe psoriasis , 2009 .

[36]  N. K. Jain,et al.  Niosomes As Drug Carriers , 1996 .

[37]  P. Prabhakara,et al.  Development and Characterization of Non-Ionic Surfactant Vesicles(Niosomes) for Oral delivery of Lornoxicam , 2012 .

[38]  Lirong Teng,et al.  Development of a novel niosomal system for oral delivery of Ginkgo biloba extract , 2013, International journal of nanomedicine.

[39]  Javad Zavar Reza,et al.  Paclitaxel and curcumin coadministration in novel cationic PEGylated niosomal formulations exhibit enhanced synergistic antitumor efficacy , 2018, Journal of Nanobiotechnology.

[40]  J. Kreuter,et al.  Colloidal Drug Delivery Systems , 1994 .

[41]  Sung Hoon Kim,et al.  Paeonol inhibits anaphylactic reaction by regulating histamine and TNF-alpha. , 2004, International Immunopharmacology.

[42]  B. Lentz,et al.  Membrane “fluidity” as detected by diphenylhexatriene probes , 1989 .

[43]  O. Sammour,et al.  Effect of some formulation parameters on flurbiprofen encapsulation and release rates of niosomes prepared from proniosomes. , 2008, International journal of pharmaceutics.

[44]  Sanghwa Han Structure of Ascorbyl Palmitate Bilayers (Aspasomes) from Molecular Dynamics Simulation , 2018 .

[45]  J. Manosroi,et al.  Characteristics of niosomes prepared by supercritical carbon dioxide (scCO2) fluid. , 2008, International journal of pharmaceutics.

[46]  C. Charcosset,et al.  Liposome preparation using a hollow fiber membrane contactor--application to spironolactone encapsulation. , 2011, International journal of pharmaceutics.

[47]  R. Mujoriya,et al.  Niosomal Drug Delivery System: The Magic Bullet , 2011 .

[48]  H. Junginger,et al.  Interactions of elastic and rigid vesicles with human skin in vitro: electron microscopy and two-photon excitation microscopy. , 1999, Biochimica et biophysica acta.

[49]  Chen Li,et al.  Co-delivery of doxorubicin and curcumin by pH-sensitive prodrug nanoparticle for combination therapy of cancer , 2016, Scientific Reports.

[50]  M. Jufri,et al.  Formulation of niosomal gel containing green tea extract (Camellia sinensis L. Kuntze) using thin-layer hydration , 2017 .

[51]  A. Mamelak,et al.  Targeted delivery of antitumoral therapy to glioma and other malignancies with synthetic chlorotoxin (TM-601) , 2007, Expert opinion on drug delivery.

[52]  T. Maekawa,et al.  Formulation, characterization and evaluation of morusin loaded niosomes for potentiation of anticancer therapy , 2018, RSC advances.

[53]  J. Manosroi,et al.  Anti-inflammatory activity of gel containing novel elastic niosomes entrapped with diclofenac diethylammonium. , 2008, International journal of pharmaceutics.

[54]  A. Elkordy,et al.  The Effects of Hydration Parameters and Co-Surfactants on Methylene Blue-Loaded Niosomes Prepared by the Thin Film Hydration Method , 2019, Pharmaceuticals.

[55]  J. Manosroi,et al.  Transdermal absorption enhancement of papain loaded in elastic niosomes incorporated in gel for scar treatment. , 2013, European journal of pharmaceutical sciences : official journal of the European Federation for Pharmaceutical Sciences.

[56]  Deqing Sun,et al.  Enhanced antitumor activity and attenuated cardiotoxicity of Epirubicin combined with Paeonol against breast cancer , 2016, Tumor Biology.

[57]  Sandeep Kumar,et al.  NIOSOMES: PRESENT SCENARIO AND FUTURE ASPECTS , 2018, Journal of Drug Delivery and Therapeutics.

[58]  Y. Perrie,et al.  Characterization and optimization of bilosomes for oral vaccine delivery , 2013, Journal of drug targeting.

[59]  A. Saini,et al.  NIOSOMES: A NOVEL DRUG DELIVERY SYSTEM , 2011 .

[60]  R Hori,et al.  Human P-glycoprotein transports cortisol, aldosterone, and dexamethasone, but not progesterone. , 1992, The Journal of biological chemistry.

[61]  Ahmed Abdelbary,et al.  Design and optimization of topical methotrexate loaded niosomes for enhanced management of psoriasis: application of Box-Behnken design, in-vitro evaluation and in-vivo skin deposition study. , 2015, International journal of pharmaceutics.

[62]  A. Florence,et al.  Some properties of extruded non-ionic surfactant micro-tubes. , 2003, International journal of pharmaceutics.

[63]  R. Cuomo,et al.  S100B Inhibitor Pentamidine Attenuates Reactive Gliosis and Reduces Neuronal Loss in a Mouse Model of Alzheimer's Disease , 2015, BioMed research international.

[64]  A. Luciani,et al.  Glucose-receptor MR imaging of tumors: study in mice with PEGylated paramagnetic niosomes. , 2004, Radiology.

[65]  N. Venkatesh,et al.  Smart niosomes of temozolomide for enhancement of brain targeting , 2018, Nanobiomedicine.

[66]  D. Rhodes,et al.  Proniosomes: a novel drug carrier preparation. , 1999, International journal of pharmaceutics.

[67]  A. Radhi BENAZEPRIL HYDROCHLORIDE LOADED NIOSOMAL FORMULATION FOR ORAL DELIVERY: FORMULATION AND CHARACTERIZATION , 2018, International Journal of Applied Pharmaceutics.

[68]  Wyatt N Vreeland,et al.  Controlled self-assembly of monodisperse niosomes by microfluidic hydrodynamic focusing. , 2010, Langmuir : the ACS journal of surfaces and colloids.

[69]  Karim Masud Kazi,et al.  Niosome: A future of targeted drug delivery systems , 2010, Journal of advanced pharmaceutical technology & research.

[70]  Pratyawadee Singhsa,et al.  Influence of chemical penetration enhancers on skin permeability of ellagic acid-loaded niosomes , 2013 .

[71]  Saeid Moghassemi,et al.  Nano-niosomes as nanoscale drug delivery systems: an illustrated review. , 2014, Journal of controlled release : official journal of the Controlled Release Society.

[72]  L. T. McGrath,et al.  Comparison of two fluorescent probes for the measurement of erythrocyte membrane fluidity in renal dialysis patients , 1995, Irish journal of medical science.

[73]  F. Rinaldi,et al.  Novel pH-sensitive non-ionic surfactant vesicles: comparison between Tween 21 and Tween 20. , 2011, Colloids and surfaces. B, Biointerfaces.

[74]  F. Sugawara,et al.  Characterization of vesicles prepared with various non-ionic surfactants mixed with cholesterol , 2003 .

[75]  A. Hadjizadeh,et al.  Formulation and Characterization of Bovine Serum Albumin-Loaded Niosome , 2016, AAPS PharmSciTech.

[76]  Xiaofei Zhang,et al.  Paeonol-Loaded Ethosomes as Transdermal Delivery Carriers: Design, Preparation and Evaluation , 2018, Molecules.

[77]  A. Goepferich,et al.  Targeting the Central Nervous System (CNS): A Review of Rabies Virus-Targeting Strategies. , 2017, Molecular pharmaceutics.

[78]  D. Mishra,et al.  Niosomes: a controlled and novel drug delivery system. , 2011, Biological & pharmaceutical bulletin.

[79]  K. Li,et al.  Studies on a high encapsulation of colchicine by a niosome system. , 2002, International journal of pharmaceutics.

[80]  David J Weber,et al.  The evolution of S100B inhibitors for the treatment of malignant melanoma. , 2013, Future medicinal chemistry.

[81]  Srinivas Reddy Devireddy,et al.  Formulation and evaluation of fluconazole pro-niosomal gel for topical administration , 2014 .

[82]  Bhupinder Singh,et al.  Novel drug delivery systems in topical treatment of psoriasis: rigors and vigors. , 2010, Indian journal of dermatology, venereology and leprology.

[83]  B. Godin,et al.  Ethosomes - novel vesicular carriers for enhanced delivery: characterization and skin penetration properties. , 2000, Journal of controlled release : official journal of the Controlled Release Society.

[84]  I. Sharifi,et al.  Antileishmanial activity and immune modulatory effects of benzoxonium chloride and its entrapped forms in niosome on Leishmania tropica , 2019, Journal of Parasitic Diseases.

[85]  Huanxiang Liu,et al.  Preparation and In vitro Evaluation of Ethosomal Total Alkaloids of Sophora alopecuroides Loaded by a Transmembrane pH-Gradient Method , 2010, AAPS PharmSciTech.

[86]  V. Mayen,et al.  Potential use of niosomes for encapsulation of nisin and EDTA and their antibacterial activity enhancement , 2011 .

[87]  G. Gutiérrez,et al.  Formulation of resveratrol entrapped niosomes for topical use. , 2015, Colloids and surfaces. B, Biointerfaces.

[88]  G. Maira,et al.  Intracerebral Diffusion of Paramagnetic Cationic Liposomes Containing Gd(DTPA)2- Followed by MRI Spectroscopy: Assessment of Patternc Diffusion and Time Steadiness of a Non-Viral Vector Model , 2006, International journal of immunopathology and pharmacology.

[89]  V. Junyaprasert,et al.  Effect of Charged and Non-ionic Membrane Additives on Physicochemical Properties and Stability of Niosomes , 2008, AAPS PharmSciTech.

[90]  Xiuwen Zhu,et al.  Anti-proliferative effects of paeonol on human prostate cancer cell lines DU145 and PC-3 , 2016, Journal of Physiology and Biochemistry.

[91]  A. Ahad,et al.  Formulation and optimization of niosomes for topical diacerein delivery using 3-factor, 3-level Box-Behnken design for the management of psoriasis. , 2016, Materials science & engineering. C, Materials for biological applications.

[92]  A. Schätzlein,et al.  The skin: a pathway for systemic treatment with patches and lipid-based agent carriers , 1996 .

[93]  R. Weissleder,et al.  Molecular imaging of gene therapy for cancer , 2004, Gene Therapy.

[94]  G. Fetih,et al.  Niosomes as transdermal drug delivery system for celecoxib: in vitro and in vivo studies , 2016, Polymer Bulletin.

[95]  Sanyog Jain,et al.  Cholera toxin B subunit conjugated bile salt stabilized vesicles (bilosomes) for oral immunization. , 2004, International journal of pharmaceutics.

[96]  Yifeng Pan,et al.  Reversion of multidrug resistance by co-encapsulation of doxorubicin and curcumin in chitosan/poly(butyl cyanoacrylate) nanoparticles. , 2012, International journal of pharmaceutics.

[97]  M. R. Mozafari,et al.  Cytotoxicity evaluation of anionic nanoliposomes and nanolipoplexes prepared by the heating method without employing volatile solvents and detergents. , 2007, Die Pharmazie.

[98]  M. R. Mozafari,et al.  Construction of stable anionic liposome-plasmid particles using the heating method: a preliminary investigation. , 2002, Cellular & molecular biology letters.

[99]  Lisbeth Illum,et al.  Nanoparticles for direct nose-to-brain delivery of drugs. , 2009, International journal of pharmaceutics.

[100]  E. A. Nunan,et al.  In Vitro Skin Permeation and Retention of Paromomycin from Liposomes for Topical Treatment of the Cutaneous Leishmaniasis , 2004, Drug development and industrial pharmacy.

[101]  G. Gutiérrez,et al.  Preparation and characterization of niosomes containing resveratrol , 2013 .

[102]  M. Sasidharan,et al.  Self-degrading niosomes for encapsulation of hydrophilic and hydrophobic drugs: An efficient carrier for cancer multi-drug delivery. , 2015, Materials science & engineering. C, Materials for biological applications.

[103]  G. H. Coombs,et al.  Non‐ionic surfactant vesicles, niosomes, as a delivery system for the anti‐leishmanial drug, sodium stibogluconate , 1986, The Journal of pharmacy and pharmacology.

[104]  Niosomes as candidate bioconjugates for imaging and pH-sensitive drug delivery nanocarriers for rare pediatric tumors , 2013 .

[105]  K. Fung,et al.  Pharmacological investigations of the anti-diabetic effect of Cortex Moutan and its active component paeonol. , 2007, Phytomedicine : international journal of phytotherapy and phytopharmacology.

[106]  E. Uronnachi Formulation and Evaluation of Niosomes of Benzyl Penicillin , 2013 .

[107]  B. Wang,et al.  Study on the physicochemical properties and anti‐inflammatory effects of paeonol in rats with TNBS‐induced ulcerative colitis , 2017, International immunopharmacology.

[108]  A. Schätzlein,et al.  Polyhedral Non‐ionic Surfactant Vesicles , 1997, The Journal of pharmacy and pharmacology.

[109]  S. Saha,et al.  Simultaneous delivery of doxorubicin and curcumin encapsulated in liposomes of pegylated RGDK-lipopeptide to tumor vasculature. , 2014, Biomaterials.

[110]  D. Gopinath,et al.  Ascorbyl palmitate vesicles (Aspasomes): formation, characterization and applications. , 2004, International journal of pharmaceutics.

[111]  G. Radha,et al.  A review on proniosomal drug delivery system for targeted drug action , 2013, Journal of basic and clinical pharmacy.

[112]  C. Pazos,et al.  Nanodesign of olein vesicles for the topical delivery of the antioxidant resveratrol , 2013, The Journal of pharmacy and pharmacology.

[113]  J. Bouwstra,et al.  LARGE DISK-SHAPED STRUCTURES (DISCOMES) IN NONIONIC SURFACTANT VESICLE TO MICELLE TRANSITIONS , 1992 .

[114]  A. Madni,et al.  Enhancement of Dissolution and Skin Permeability of Pentazocine by Proniosomes and Niosomal Gel , 2018, AAPS PharmSciTech.

[115]  Andrea Sbarbati,et al.  A novel near-infrared indocyanine dye-polyethylenimine conjugate allows DNA delivery imaging in vivo. , 2008, Bioconjugate chemistry.

[116]  J. Kremer,et al.  Etanercept added to background methotrexate therapy in patients with rheumatoid arthritis: continued observations. , 2003, Arthritis and rheumatism.

[117]  R. Cuomo,et al.  S100B-p53 disengagement by pentamidine promotes apoptosis and inhibits cellular migration via aquaporin-4 and metalloproteinase-2 inhibition in C6 glioma cells. , 2015, Oncology letters.

[118]  M. H. Aboul-Einien,et al.  Ascorbic acid derivative-loaded modified aspasomes: formulation, in vitro, ex vivo and clinical evaluation for melasma treatment , 2020, Journal of liposome research.

[119]  G. Cevc Transfersomes, liposomes and other lipid suspensions on the skin: permeation enhancement, vesicle penetration, and transdermal drug delivery. , 1996, Critical reviews in therapeutic drug carrier systems.

[120]  G. Caracciolo,et al.  Effect of cholesterol on the formation and hydration behavior of solid-supported niosomal membranes. , 2010, Langmuir.

[121]  J. Manosroi,et al.  Transdermal absorption enhancement through rat skin of gallidermin loaded in niosomes. , 2010, International journal of pharmaceutics.

[122]  B. Wang,et al.  Beneficial anti-inflammatory effect of paeonol self-microemulsion-loaded colon-specific capsules on experimental ulcerative colitis rats , 2018, Artificial cells, nanomedicine, and biotechnology.

[123]  I. I. Abu Hashim,et al.  Pivotal role of Acitretin nanovesicular gel for effective treatment of psoriasis: ex vivo–in vivo evaluation study , 2018, International journal of nanomedicine.

[124]  D. Aggarwal,et al.  Vesicular systems in ocular drug delivery: an overview. , 2004, International journal of pharmaceutics.

[125]  M. Haider,et al.  In vitro and in vivo investigation for optimization of niosomal ability for sustainment and bioavailability enhancement of diltiazem after nasal administration , 2017, Drug delivery.

[126]  I. Sharifi,et al.  A Novel Niosomal Combination of Selenium Coupled with Glucantime against Leishmania tropica , 2019, The Korean journal of parasitology.

[127]  Alamethicin-lipid interaction studied by energy dispersive X-ray diffraction. , 2009, Colloids and surfaces. B, Biointerfaces.

[128]  R. Assi,et al.  Ethosomal nanocarriers: the impact of constituents and formulation techniques on ethosomal properties, in vivo studies, and clinical trials , 2016, International journal of nanomedicine.

[129]  J. Lakowicz Principles of fluorescence spectroscopy , 1983 .

[130]  M. R. Kumar,et al.  Analytical methods for assay of ellagic acid and its solubility studies. , 2006, Journal of pharmaceutical and biomedical analysis.

[131]  David Heber,et al.  Bioavailability of ellagic acid in human plasma after consumption of ellagitannins from pomegranate (Punica granatum L.) juice. , 2004, Clinica chimica acta; international journal of clinical chemistry.

[132]  R. Alany,et al.  Recent advances in non-ionic surfactant vesicles (niosomes): self-assembly, fabrication, characterization, drug delivery applications and limitations , 2014, Drug delivery.

[133]  Ijeoma F. Uchegbu,et al.  Non-ionic surfactant based vesicles (niosomes) in drug delivery , 1998 .

[134]  H. Junginger,et al.  Niosomes for oral delivery of peptide drugs , 1992 .

[135]  J. Cummings,et al.  The Distribution of Doxorubicin in Mice Following Administration in Niosomes , 1988, The Journal of pharmacy and pharmacology.

[136]  S. Naderinezhad,et al.  Co-delivery of hydrophilic and hydrophobic anticancer drugs using biocompatible pH-sensitive lipid-based nano-carriers for multidrug-resistant cancers , 2017 .

[137]  M. Bally,et al.  Uptake of antineoplastic agents into large unilamellar vesicles in response to a membrane potential. , 1985, Biochimica et biophysica acta.

[138]  S. Chong,et al.  A novel vesicular carrier, transethosome, for enhanced skin delivery of voriconazole: characterization and in vitro/in vivo evaluation. , 2012, Colloids and surfaces. B, Biointerfaces.

[139]  T. Liu,et al.  Evaluation of paeonol‐loaded transethosomes as transdermal delivery carriers , 2017, European journal of pharmaceutical sciences : official journal of the European Federation for Pharmaceutical Sciences.

[140]  M. Bally,et al.  Generation of multilamellar and unilamellar phospholipid vesicles , 1986 .

[141]  I. Uchegbu,et al.  Non-ionic surfactant vesicles (niosomes): Physical and pharmaceutical chemistry , 1995 .

[142]  Mengyao Qin,et al.  Hyaluronic acid-coated niosomes facilitate tacrolimus ocular delivery: Mucoadhesion, precorneal retention, aqueous humor pharmacokinetics, and transcorneal permeability. , 2016, Colloids and surfaces. B, Biointerfaces.

[143]  Praveen Kumar,et al.  Formulation of Niosomal Gel for Enhanced Transdermal Lopinavir Delivery and Its Comparative Evaluation with Ethosomal Gel , 2012, AAPS PharmSciTech.

[144]  A. Florence,et al.  The effect of non‐ionic surfactant vesicle (niosome) entrapment on the absorption and distribution of methotrexate in mice , 1985, The Journal of pharmacy and pharmacology.

[145]  A. Khamesipour,et al.  Preparation and evaluation of niosomes containing autoclaved Leishmania major: a preliminary study , 2012, Journal of microencapsulation.

[146]  A. D. de Kroon,et al.  Ligation Strategies for Targeting Liposomal Nanocarriers , 2014, BioMed research international.

[147]  S. Saraf,et al.  Niosomal Delivery of Isoniazid -Development and Characterization , 2011 .

[148]  H. Abdelkader,et al.  Preparation, characterization and evaluation of novel elastic nano-sized niosomes (ethoniosomes) for ocular delivery of prednisolone , 2014, Journal of liposome research.

[149]  Xiangliang Yang,et al.  Codelivery of doxorubicin and curcumin with lipid nanoparticles results in improved efficacy of chemotherapy in liver cancer , 2014, International journal of nanomedicine.

[150]  Pratyawadee Singhsa,et al.  Physicochemical properties and skin permeation of Span 60/Tween 60 niosomes of ellagic acid. , 2012, International journal of pharmaceutics.

[151]  J. Lambert,et al.  Extended follow-up of peripheral neuropathy in patients with AIDS and AIDS-related complex treated with dideoxyinosine. , 1992, Journal of acquired immune deficiency syndromes.

[152]  A. Fadda,et al.  Nanocarriers for antioxidant resveratrol: formulation approach, vesicle self-assembly and stability evaluation. , 2013, Colloids and surfaces. B, Biointerfaces.

[153]  I. Sarkar,et al.  Photophysical behavior of a new cholesterol attached coumarin derivative and fluorescence spectroscopic studies on its interaction with bile salt systems and lipid bilayer membranes. , 2014, Physical chemistry chemical physics : PCCP.

[154]  D. Sharma,et al.  Niosomes as Novel Drug Delivery System: Review Article , 2018 .

[155]  M. Carafa,et al.  Non-phospholipid vesicles for pulmonary glucocorticoid delivery. , 2005, European journal of pharmaceutics and biopharmaceutics : official journal of Arbeitsgemeinschaft fur Pharmazeutische Verfahrenstechnik e.V.

[156]  L. Casettari,et al.  Chitosan in nasal delivery systems for therapeutic drugs. , 2014, Journal of controlled release : official journal of the Controlled Release Society.

[157]  J. Brewer,et al.  The adjuvant activity of non-ionic surfactant vesicles (niosomes) on the BALB/c humoral response to bovine serum albumin. , 1992, Immunology.

[158]  M. Carafa,et al.  Designing novel pH-sensitive non-phospholipid vesicle: characterization and cell interaction. , 2006, European Journal of Pharmaceutical Sciences.

[159]  P. Pawar,et al.  Recent Trends in Niosome as Vesicular Drug Delivery System , 2012 .

[160]  R. Alany,et al.  Design and evaluation of controlled-release niosomes and discomes for naltrexone hydrochloride ocular delivery. , 2011, Journal of pharmaceutical sciences.

[161]  Min-yan Wei,et al.  Advances of Non-Ionic Surfactant Vesicles (Niosomes) and Their Application in Drug Delivery , 2019, Pharmaceutics.

[162]  Huixia Lv,et al.  Formulation, characterization and pharmacokinetics of Morin hydrate niosomes prepared from various non-ionic surfactants. , 2013, International journal of pharmaceutics.

[163]  D. Passeri,et al.  Chitosan Glutamate-Coated Niosomes: A Proposal for Nose-to-Brain Delivery , 2018, Pharmaceutics.

[164]  D. Peng,et al.  PEGylated non-ionic surfactant vesicles as drug delivery systems for Gambogenic acid , 2013, Drug delivery.

[165]  R. Guo,et al.  Investigation of PEG 6000/Tween 80/Span 80/H2O niosome microstructure , 2007 .

[166]  H. Danafar,et al.  Niosome: A Promising Nanocarrier for Natural Drug Delivery through Blood-Brain Barrier , 2018, Advances in pharmacological sciences.

[167]  F. Martin Pharmaceutical manufacturing of liposomes , 1990 .

[168]  S. Harikumar,et al.  Design and development of cefdinir niosomes for oral delivery , 2013, Journal of pharmacy & bioallied sciences.

[169]  M. Carafa,et al.  Lidocaine-loaded non-ionic surfactant vesicles: characterization and in vitro permeation studies. , 2002, International journal of pharmaceutics.

[170]  T. Pincus,et al.  Long term safety of methotrexate in routine clinical care: discontinuation is unusual and rarely the result of laboratory abnormalities , 2004, Annals of the rheumatic diseases.

[171]  E. Bendas,et al.  Hydroxychloroquine niosomes: a new trend in topical management of oral lichen planus. , 2013, International journal of pharmaceutics.

[172]  B. Larijani,et al.  Uptake and transport of insulin across intestinal membrane model using trimethyl chitosan coated insulin niosomes. , 2015, Materials science & engineering. C, Materials for biological applications.

[173]  S. Andò,et al.  Transferrin-conjugated pluronic niosomes as a new drug delivery system for anticancer therapy. , 2013, Langmuir : the ACS journal of surfaces and colloids.

[174]  F. Iemma,et al.  Preparation and characterization of bolaform surfactant vesicles. , 2005, Colloids and surfaces. B, Biointerfaces.

[175]  J. Manosroi,et al.  Transdermal absorption enhancement of gel containing elastic niosomes loaded with gallic acid from Terminalia chebula galls , 2011, Pharmaceutical biology.